NCT00840762View on ClinicalTrials.gov

A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication

PHASE4UnknownINTERVENTIONAL
Enrollment

756

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

February 29, 2012

Study Completion Date

July 31, 2012

Conditions
HIV-1HIV Infections
Interventions
OTHER

VircoType HIV-1 genotypic interpretation

VircoType HIV-1 genotypic interpretation

OTHER

Local Expert Review of HIV Genotypic resistance testing

Local Expert Review of HIV Genotypic resistance testing

Trial Locations (1)

60612

RECRUITING

The Ruth M. Rothstein CORE Center, Chicago

Sponsors

Collaborators (1)

Virco
All Listed Sponsors
collaborator

Virco

INDUSTRY

lead

Ruth M. Rothstein CORE Center

OTHER

NCT00840762 - A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication | Biotech Hunter | Biotech Hunter